Karen-Leigh Edwards
Directeur Technique/Scientifique/R&D chez OCULAR THERAPEUTIX, INC.
Postes actifs de Karen-Leigh Edwards
Sociétés | Poste | Début | Fin |
---|---|---|---|
OCULAR THERAPEUTIX, INC. | Directeur Technique/Scientifique/R&D | 28/09/2021 | - |
Historique de carrière de Karen-Leigh Edwards
Anciens postes connus de Karen-Leigh Edwards
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Directeur des opérations | - | - |
Formation de Karen-Leigh Edwards
MIT Sloan School of Management | Masters Business Admin |
University of Kansas | Doctorate Degree |
University of London | Graduate Degree |
University Of The West Indies | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Royaume-Uni | 2 |
Jamaïque | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Chief Operating Officer | 1 |
Masters Business Admin | 1 |
Sectorielle
Consumer Services | 5 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Karen-Leigh Edwards
- Expérience